NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

They haven't unblinded because they've not been advised to do so by the Scientific Advisory Board. They'll unblind it when they've obtained the data they'll need to ensure a statistically significant trial, meaning the p-value and hazard ratios are what they need to be to establish that the trial proved what it set out to prove.

Those on the other side would have you believe that either the data will never be statistically significant, or that whatever the data is, is won't change - not from last year's Spring refresh, and from this year's Spring refresh. They hope to pressure the company into unblinding sooner in the hopes that in doing so, the company will make a fatal error by having done so too soon. This may be coming simply from the hedge funds that are shorting NWBO, in the hopes of basically sending the company into bankruptcy, or those hedge funds could be working in league to destroy NWBO with a larger pharma group or two, who may have also played a role in funding this. This is my opinion, but you asked for it.